GI
DGX icon

GAMMA Investing’s Quest Diagnostics DGX Stock Holding History

GAMMA Investing’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
5,295
+1,411
+36% +$277K 0.04% 361
2026
Q1 		$761K Buy
3,884
+394
+11% +$76.6K 0.04% 428
2025
Q4 		$606K Sell
3,490
-21
-0.6% -$3.82K 0.03% 465
2025
Q3 		$669K Buy
3,511
+520
+17% +$92.3K 0.04% 417
2025
Q2 		$537K Buy
2,991
+361
+14% +$62.7K 0.03% 456
2025
Q1 		$445K Buy
2,630
+728
+38% +$120K 0.03% 464
2024
Q4 		$287K Buy
1,902
+594
+45% +$92.4K 0.02% 556
2024
Q3 		$203K Buy
1,308
+445
+52% +$66.5K 0.02% 618
2024
Q2 		$118K Buy
863
+211
+32% +$28.9K 0.02% 691
2024
Q1 		$86.8K Buy
652
+133
+26% +$17.3K 0.02% 717
2023
Q4 		$66.7K Buy
+519
New +$68.2K 0.02% 737

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GAMMA Investing's DGX Position: Q2 2026 in Review

GAMMA Investing increased its Quest Diagnostics (DGX) stake by 36% in Q2 2026, buying an estimated $277K and bringing the position to 5,295 shares worth $1.12M. The position accounts for 0.04% of the portfolio, ranked #361.

GAMMA Investing first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 264 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • GAMMA Investing held 5,295 shares of Quest Diagnostics worth $1.12M as of Q2 2026.
  • GAMMA Investing bought 1,411 Quest Diagnostics shares in Q2 2026, an estimated $277K.
  • Quest Diagnostics made up 0.04% of GAMMA Investing's portfolio in Q2 2026, its #361 holding.
  • GAMMA Investing first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • 264 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.